Genetic features of neuroblastic tumors associated with opsoclonus-myoclonus syndrome opens up the possibility for detection in peripheral blood

Expert Rev Neurother. 2016 May;16(5):465-7. doi: 10.1586/14737175.2016.1163221. Epub 2016 Apr 6.

Authors

Ana P Berbegall¹, Ricardo López-Almaraz², Samuel Navarro¹, Rosa Noguera¹

Affiliations

¹ a Pathology Department , Medical School, University of Valencia, INCLIVA , Valencia , Spain.
² b Pediatric Oncology and Hematology , Hospital Universitario Cruces , Bilbao , Spain.

PMID: 26949993
DOI: 10.1586/14737175.2016.1163221

No abstract available

Keywords: Circulating tumor DNA; MYCN; neuroblastic tumors; opsoclonus-myoclonus syndrome; segmental chromosome alteration.

Publication types

Editorial